Photograph of Chalana N. Damron Download V-card

Chalana N. Damron

Phone: +1 202.624.2566
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Selected for the 2019
Pathfinder Program
of the Leadership Council
on Legal Diversity

Chalana N. Damron is a counsel in the firm's Mass Tort, Product, and Consumer Litigation Group. Chalana’s litigation practice spans numerous industries including aviation, healthcare, pharmaceutical, and food & beverage. She represents clients in a diverse array of litigations, including commercial, antitrust, class action, and product liability.

Representative Litigation Matters

  • Representing pharmaceutical distributor in product liability litigation filed in multiple jurisdictions, both state and federal, stemming from voluntary recall.
  • Representing major domestic airline in a federal antitrust class action.
  • Represented leading snack food manufacturer in defense of breach of contract and promissory estoppel claims in Illinois federal court, obtaining summary judgment on all claims prior to trial.
  • Represented parts supplier in litigation over alleged product defect and warranty claims.
  • Represented personal care company in false advertising litigation under the Lanham Act.
Recognizing the intersection between regulatory compliance and litigation vulnerability, Chalana also leverages her litigation experience when advising FDA-regulated companies on a variety of regulatory, enforcement, and compliance matters. As part of her regulatory practice, Chalana assists clients with preparing for FDA inspections, evaluating quality systems, responding to FDA 483 observations, and becoming compliant with the Federal Food , Drug and Cosmetic Act. She regularly evaluates and offers commentary on litigation and regulatory developments impacting FDA-regulated industries, and provides clients with mechanisms to limit the risk of marketing-related challenges by plaintiffs and regulators. Additionally, Chalana develops and conducts comprehensive training programs to assist regulatory executives and marketing teams with understanding and complying with FDA regulations. 

In response to COVID-19, Chalana has leveraged her litigation and FDA experience to guide companies as they pivot their businesses to mitigate critical supply shortages throughout the country. Chalana also assists companies with navigating the myriad of federal and state regulations aimed at reducing the spread of COVID-19 and counsels clients on COVID-19 litigation strategies and defenses.

Chalana is an active participant in Crowell and Moring's pro bono program and focuses on housing issues, such as housing discrimination and landlord-tenant disputes. She has represented plaintiffs in two fair housing cases brought in the Eastern District of Virginia.
Chalana received her J.D. from the University of Virginia School of Law where she was a member of the Black Law Student Association's Trial Advocacy Team. She earned a B.S. in political science, summa cum laude, from Christopher Newport University.


  • Christopher Newport University, B.S. political science (2009) summa cum laude
  • University of Virginia School of Law, J.D. (2013)


Admitted to practice: District of Columbia, Virginia, U.S. District Court for the Eastern District of Virginia

View More

"Supply Chain – Where Adversaries and Adversity Meet," OOPS 20/20 - Setting Your Sights (October 19, 2020). Presenters: Paul Freeman, Chalana N. Damron, Abigail Stokes, and Stephanie L. Crawford.
"FDA Warning Letter Sends Pointed Message to Industry about EUAs and Compliance," Mass Tort, Product, and Consumer Litigation Alert (October 9, 2020). Contacts: John Fuson, Chalana N. Damron, Mariam Sarwar
Client Alert / Newsletter
"Anticipating a COVID Vaccine: Considerations for Employers and Consumer Facing Businesses," Crowell & Moring Webinar (September 21, 2020). Presenters: John Fuson, Thomas P. Gies, Chalana N. Damron, and Katie Erno.
"Global COVID-19 and Sports; Threats and Responses Exposure Claims and Liability Mitigation Considerations," Crowell & Moring (August 15, 2020). Authors: Thomas P. Gies, Kristof Roox, Laurence Winston, and Chalana N. Damron.
"Global COVID-19 and Sports: Threats and Responses," ILI Webinar (July 30, 2020). Presenters: Thomas P. Gies, Kristof Roox, and Chalana N. Damron.
"FDA Plans to Resume Domestic Facility Inspections," Mass Tort, Product, and Consumer Litigation Alert (July 17, 2020). Contacts: John Fuson, Chalana N. Damron, Emily Tucker
Client Alert / Newsletter
"Reopening and COVID-19 Workplace Litigation To Date: Lessons Learned and Practical Advice to Position Your Company to Mitigate Risk," Crowell & Moring Webinar (July 14, 2020). Presenters: Cheryl A. Falvey, Thomas P. Gies, and Chalana N. Damron.
"FDA Advises Consumers to Avoid Hand Sanitizers Found to Contain Methanol," Mass Tort, Product, and Consumer Litigation Alert (June 23, 2020). Contacts: John Fuson, Chalana N. Damron
Client Alert / Newsletter
"COVID-19 Product Liability And The 'Innocent Seller'," Law360 (June 8, 2020). Authors: Daniel T. Campbell, Chalana Netasha Damron, Mimi S. Dennis, William C. Pellett, and Emily Tucker.
"HHS Advisory Opinion Clarifies PREP Act Preemption Measures and Protection for Pharmacists," Mass Tort, Product, and Consumer Litigation Alert (May 27, 2020). Contacts: John Fuson, Chalana N. Damron, Mariam Sarwar
Client Alert / Newsletter

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with more than 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, London, Brussels, and Shanghai.

View Desktop Site | Mobile Sitemap

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2020
Attorney advertising - prior results do not guarantee a similar outcome.